ENTERO
Entero Healthcare Solutions Limited (ENTERO) Stock Analysis
Entero Healthcare Solutions Limited is an Indian healthcare distribution and pharmacy-platform company. It supplies medicines and related services to pharmacies and healthcare providers through a technology-enabled network. The company supports last-mile pharmaceutical distribution. It is listed on Indian stock exchanges.
Healthcare › Medical Distribution
₹1,795.00
-1.12% 1W | +54.30% 52W
Market Cap
7.8k CR
P/E Ratio
62.4
52W High
₹1920
52W Low
₹944
Div. Yield
0%
Beta
-0.5
50 DMA
₹1469
200 DMA
₹1225.7
Profit Margin
1.8%
Inst. Own.
21.4%
📈 CONSOLIDATING UP
📈 CONSOLIDATING UP
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 899 | 996 | 993 | 1,034 | 1,097 | 1,301 | 1,359 | 1,339 | 1,404 | 1,571 | 1,707 | 1,910 | 1,940 |
| Expenses | 873 | 968 | 964 | 1,005 | 1,067 | 1,258 | 1,309 | 1,290 | 1,354 | 1,509 | 1,639 | 1,824 | 1,844 |
| Operating Profit | 26 | 29 | 29 | 29 | 30 | 42 | 50 | 49 | 50 | 62 | 68 | 86 | 97 |
| OPM % | 2.9% | 2.9% | 2.9% | 2.8% | 2.8% | 3.3% | 3.7% | 3.6% | 3.6% | 4.0% | 4.0% | 4.5% | 5% |
| Other Income | 1 | 2 | 2 | 9 | 13 | 11 | 8 | 7 | 6 | 5 | -4 | 4 | 3 |
| Interest | 14 | 18 | 16 | 17 | 10 | 11 | 10 | 10 | 11 | 12 | 14 | 17 | 21 |
| Depreciation | 6 | 6 | 6 | 7 | 7 | 7 | 8 | 8 | 9 | 10 | 10 | 15 | 12 |
| Profit before tax | 7 | 7 | 8 | 14 | 27 | 35 | 39 | 37 | 36 | 45 | 40 | 58 | 67 |
| Tax % | 6% | 23% | 16% | -56% | 25% | 25% | 25% | 16% | 17% | 18% | 16% | 22% | 22% |
| Net Profit | 6 | 5 | 7 | 21 | 21 | 26 | 29 | 31 | 30 | 37 | 34 | 45 | 52 |
| EPS in Rs | 15.18 | 3.19 | 4.22 | 4.82 | 4.62 | 5.43 | 5.85 | 5.90 | 6.39 | 7.26 | 6.35 | 6.44 | 8.77 |
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,350 | 1,773 | 2,522 | 3,300 | 3,922 | 5,096 | 6,591 | 7,128 |
| Expenses | 1,326 | 1,758 | 2,498 | 3,236 | 3,810 | 4,924 | 6,325 | 6,815 |
| Operating Profit | 23 | 15 | 24 | 64 | 112 | 172 | 266 | 313 |
| OPM % | 1.7% | 0.8% | 1.0% | 1.9% | 2.9% | 3.4% | 4.0% | 4.4% |
| Other Income | 5 | 11 | 4 | 6 | 14 | 39 | 11 | 8 |
| Interest | 13 | 20 | 29 | 49 | 66 | 42 | 54 | 64 |
| Depreciation | 12 | 16 | 20 | 24 | 25 | 31 | 43 | 47 |
| Profit before tax | 4 | -11 | -20 | -4 | 36 | 139 | 179 | 210 |
| Tax % | 67% | 42% | 49% | 201% | -12% | 23% | 19% | |
| Net Profit | 1 | -15 | -29 | -11 | 40 | 107 | 146 | 168 |
| EPS in Rs | 93.81 | -1,550.90 | -77.71 | -28.12 | 8.99 | 21.79 | 26.44 | 28.82 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 26.0% | 30.0% | – |
| Profit CAGR | 130.0% | 57.0% | – |
Shareholding Pattern
Promoters52.42%
FIIs17.21%
DIIs10.19%
Public20.19%
Promoters52.42%
FIIs14.68%
DIIs9.64%
Public23.26%
Promoters52.42%
FIIs5.14%
DIIs16.42%
Public26.03%
Promoters52.42%
FIIs4.03%
DIIs16.62%
Public26.94%
Promoters52.40%
FIIs4.36%
DIIs15.48%
Public27.77%
Promoters52.44%
FIIs23.30%
DIIs2.28%
Public21.99%
Promoters52.42%
FIIs19.92%
DIIs9.63%
Public18.03%
Promoters52.42%
FIIs4.03%
DIIs16.62%
Public26.94%
Promoters52.40%
FIIs4.36%
DIIs15.48%
Public27.77%
ENTERO
Holdings Analysis
Key strengths & risk signals
76
Overall
63
Fundamental
90
Technical
Risks (1)
LOW MARGIN! 1.8% profit margin - thin profits.
Strengths (4)
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
BULLISH TREND! 50-day average (1469.0) is above 200-day average (1225.7) - positive signal.
EXCELLENT YEAR! Stock gained 54.3% in the last year.
BULLISH SENTIMENT! In last 30 days: 15 up days, 15 down days. Avg volume on up days: 592,056 vs down days: 203,965. Ratio: 2.9x
Fundamental & Technical Analysis
76Overall
63Fundamental
90Technical
Fundamental Breakdown
Growth Quality
17/30
Revenue CAGR: 25.7% (EXCELLENT, 15/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
2/10
LOW MARGIN! 1.8% profit margin - thin profits.
PEG Valuation
7/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
14/20
MODERATE PUBLIC HOLDING! 21.99% public ownership - balanced ownership structure.
Stability Index
10/10
PERFECT RECORD! Revenue has grown consistently every year. Exceptional business stability.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (1469.0) is above 200-day average (1225.7) - positive signal.
Price Position
8/10
STRONG POSITION! Current price (1795.0) is above both moving averages.
Trend Pattern
14/20
Current trend: CONSOLIDATING UP
52W Performance
10/10
EXCELLENT YEAR! Stock gained 54.3% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 15 up days, 15 down days. Avg volume on up days: 592,056 vs down days: 203,965. Ratio: 2.9x
RSI
3/5
BULLISH! RSI at 61.9 - positive momentum.
52W Range
5/5
STRONG! Trading at 87.2% of 52W range - near yearly highs.
Momentum
3/5
MIXED MOMENTUM! Price growth is inconsistent - -1.1% (1 week), 28.1% (1 month), 65.0% (3 months).
Beta
5/5
LOW VOLATILITY! Beta of -0.50 - stable stock, less market risk.
ENTERO
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q4FY262026-06-02 | Concall PDF | |
| Q3FY262026-02-20 | Concall PDF | |
| Q2FY262025-11-20 | Concall PDF |
Peer Comparison
Healthcare · Medical Distribution · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ENTERO | ₹1,795.00 | 62.4 | 1.8% | 25.7% | – | +54.3% | 76 | CONSOLIDATING UP | +37.4% | +36.4% | +38.2% | +1.6% |
| AARTIPHARM | ₹846.50 | 37.5 | 10.4% | -2.6% | -3.3% | -8.8% | 58 | BREAKDOWN | +65.4% | +24.5% | +38.7% | -8.0% |
| SUPRIYA | ₹957.10 | 38.8 | 22.7% | 21.2% | 32.5% | +21.3% | 79 | BREAKOUT | -31.0% | -67.7% | +30.7% | -31.4% |
| MEDPLUS | ₹660.20 | 37.6 | 2.9% | 14.7% | 64.0% | -19.6% | 61 | CONSOLIDATING DOWN | -21.7% | -48.1% | +21.8% | +0.8% |
| NEPHROPLUS | ₹751.50 | 88.7 | 8.1% | 33.9% | – | +57.7% | 73 | CONSOLIDATING UP | +35.0% | +5.3% | +23.7% | +6.1% |
| SANOFI | ₹3,077.20 | 21.9 | 17.9% | -12.6% | -19.3% | -38.5% | 52 | BREAKDOWN | +20.1% | -18.6% | +7.7% | -7.3% |
| BLISSGVS | ₹661.00 | 52.4 | 13.5% | 7.2% | 22.1% | +350.0% | 78 | BREAKOUT | +16.5% | +40.7% | +37.6% | +11.1% |
| INNOVACAP | ₹1,200.00 | 44.6 | 8.8% | 20.1% | 27.5% | +36.6% | 77 | BREAKOUT | +42.3% | +15.7% | +34.0% | +5.2% |
Data from TradeAlone · Updated daily
ENTERO News
Entero Healthcare Solutions Limited (NSE: ENTERO) breaks out, moves up 5% intraday2026-08-11Entero Healthcare Solutions Limited (ENTERO) gains 10% intraday2026-08-10Entero Healthcare Solutions Limited (NSE: ENTERO) clears resistance at ₹1221, gains 8% intraday2026-08-10Entero Healthcare Solutions Limited (entero) Q1 FY27: Revenue Up 38% Yoy, Margins Improve2026-08-07Entero Healthcare Solutions Limited (ENTERO) climbs up 5% intraday2026-06-24
